Read + Share
. Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran,
Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation. Ann Intern Med 2022 Dec 6. doi: 10.7326/L22-0482.
PMID: 36469929
|
 |
|
. Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran,
Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation. Ann Intern Med 2022 Dec 6. doi: 10.7326/L22-0482.
PMID: 36469929
|
|
|
|